267 related articles for article (PubMed ID: 22867055)
21. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
[TBL] [Abstract][Full Text] [Related]
22. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
[TBL] [Abstract][Full Text] [Related]
23. The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.
Liu X; Guo R; Meng X; Fang J; Lu L
Front Immunol; 2020; 11():560744. PubMed ID: 33329521
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
Fujita Y; Yago T; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Yashiro-Furuya M; Suzuki E; Watanabe H; Kawakami A; Migita K
PLoS One; 2021; 16(8):e0255493. PubMed ID: 34351954
[TBL] [Abstract][Full Text] [Related]
25. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
[TBL] [Abstract][Full Text] [Related]
27. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
[TBL] [Abstract][Full Text] [Related]
28. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.
Kawashima M; Yamamura M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Miyawaki S; Amano T; Takeuchi T; Makino H
Arthritis Rheum; 2001 Mar; 44(3):550-60. PubMed ID: 11263769
[TBL] [Abstract][Full Text] [Related]
29. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
31. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
33. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still's disease.
Kaneko Y; Takeuchi T
Expert Opin Biol Ther; 2022 Jan; 22(1):79-85. PubMed ID: 34126828
[TBL] [Abstract][Full Text] [Related]
35. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
36. Interluekin-6 inhibitors for the treatment of adult-onset Still's disease.
Kaneko Y
Mod Rheumatol; 2022 Jan; 32(1):12-15. PubMed ID: 34894252
[TBL] [Abstract][Full Text] [Related]
37. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
38. Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Xun C; Zhao Y; Hu ZJ
Rheumatol Int; 2013 May; 33(5):1255-8. PubMed ID: 23096558
[TBL] [Abstract][Full Text] [Related]
39. TCR gamma delta + T cells in peripheral blood of patients with adult Still's disease.
Hoshino T; Ohta A; Nakao M; Ota T; Inokuchi T; Matsueda S; Gouhara R; Yamada A; Itoh K; Oizumi K
J Rheumatol; 1996 Jan; 23(1):124-9. PubMed ID: 8838520
[TBL] [Abstract][Full Text] [Related]
40. Still's disease in children and adults: a distinct pattern of acute-phase proteins.
Sobieska M; Fassbender K; Aeschlimann A; Bourgeois P; Mackiewicz S; Müller W
Clin Rheumatol; 1998; 17(3):258-60. PubMed ID: 9694067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
